Lv11
40 积分 2025-11-24 加入
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease
1小时前
已完结
Progress in treating chronic granulomatous disease
6天前
已完结
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER)
21天前
已完结
皖公网安备34019202002308
